Lindbrook Capital, LLC Rocket Pharmaceuticals, Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 114 shares of RCKT stock, worth $1,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114

Previous 217 47.47%

Holding current value

$1,340

Previous $4,000 50.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$17.6 - $25.88 $1,812 - $2,665	-103 Reduced 47.47%	114 $2,000
Q2 2024 Jul 31, 2024	BUY	$20.66 - $26.72 $888 - $1,148	43 Added 24.71%	217 $4,000
Q1 2024 Apr 25, 2024	BUY	$26.16 - $30.74 $130 - $153	5 Added 2.96%	174 $4,000
Q4 2023 Jan 31, 2024	SELL	$16.78 - $31.94 $234 - $447	-14 Reduced 7.65%	169 $5,000
Q3 2023 Oct 25, 2023	BUY	$15.07 - $24.05 $1,431 - $2,284	95 Added 107.95%	183 $3,000
Q2 2022 Aug 01, 2022	BUY	$7.96 - $16.64 $700 - $1,464	88 New	88 $1,000
Q2 2021 Jul 27, 2021	SELL	$39.41 - $47.25 $9,300 - $11,151	-236 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$43.34 - $65.91 $59,115 - $89,901	-1,364 Reduced 85.25%	236 $10,000
Q4 2020 Jan 27, 2021	SELL	$23.3 - $59.57 $2,330 - $5,957	-100 Reduced 5.88%	1,600 $88,000
Q3 2020 Nov 03, 2020	BUY	$20.5 - $28.59 $34,850 - $48,603	1,700 New	1,700 $39,000
Q2 2020 Jul 27, 2020	SELL	$13.32 - $22.61 $19,980 - $33,915	-1,500 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$11.07 - $24.23 $16,605 - $36,345	-1,500 Reduced 50.0%	1,500 $34,000
Q3 2019 Oct 31, 2019	BUY	$10.85 - $14.78 $21,700 - $29,560	2,000 Added 200.0%	3,000 $35,000
Q2 2019 Jul 24, 2019	BUY	$15.0 - $19.81 $15,000 - $19,810	1,000 New	1,000 $15,000
Q1 2019 Apr 23, 2019	SELL	$13.45 - $19.01 $6,725 - $9,505	-500 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$11.21 - $23.53 $5,605 - $11,765	500 New	500 $7,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $890M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Rocket Pharmaceuticals, Inc. Transaction History